Related Experiment Video
Updated: Aug 3, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Disposition decomposition analysis for pharmacodynamic modeling of the link compartment
1Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA.
A new disposition decomposition analysis (DDA) method models drug effects, calculating key parameters like mean transit time and biophase concentration. This approach enhances pharmacokinetic/pharmacodynamic modeling for better drug distribution analysis.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Pharmacodynamics
Background:
- Pharmacodynamic modeling is crucial for understanding drug behavior.
- Existing models may not fully capture complex drug distribution dynamics.
Purpose of the Study:
- To develop an advanced disposition decomposition analysis (DDA) method for pharmacodynamic modeling.
- To extend DDA to analyze drug distribution in heterogeneous effect compartments within generalized pharmacokinetic/pharmacodynamic (PK/PD) models.
Main Methods:
- Utilized disposition decomposition analysis (DDA) combined with the hysteresis minimization principle.
- Developed a method to calculate mean transit time and the ratio of distribution clearance to biophase distribution volume.
- Determined the drug concentration-time function at the biophase (Cb(t)).
Main Results:
- Successfully calculated key pharmacokinetic and pharmacodynamic parameters.
- Demonstrated the method's ability to model drug concentration at the effect site.
- Validated the DDA-dynamics approach using published pancuronium data.
Conclusions:
- The proposed DDA-dynamics method offers a robust framework for pharmacodynamic modeling.
- This approach enhances the analysis of drug distribution in complex PK/PD systems.
- The method provides valuable insights into drug disposition and effect site concentration.
More Related Videos
06:31Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
Published on: August 8, 2019
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two-Compartment Open Model: Overview
The...
Three-Compartment Open Model
Mechanistic Models: Overview of Compartment Models
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model